AU2021395441A1 - Mof nanoparticles - Google Patents

Mof nanoparticles Download PDF

Info

Publication number
AU2021395441A1
AU2021395441A1 AU2021395441A AU2021395441A AU2021395441A1 AU 2021395441 A1 AU2021395441 A1 AU 2021395441A1 AU 2021395441 A AU2021395441 A AU 2021395441A AU 2021395441 A AU2021395441 A AU 2021395441A AU 2021395441 A1 AU2021395441 A1 AU 2021395441A1
Authority
AU
Australia
Prior art keywords
polymer
mof
nanoparticles
coated
pcn
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2021395441A
Other languages
English (en)
Other versions
AU2021395441A9 (en
Inventor
Xu Chen
David Fairén JIMÉNEZ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cambridge Enterprise Ltd
Original Assignee
Cambridge Enterprise Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cambridge Enterprise Ltd filed Critical Cambridge Enterprise Ltd
Publication of AU2021395441A1 publication Critical patent/AU2021395441A1/en
Publication of AU2021395441A9 publication Critical patent/AU2021395441A9/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
AU2021395441A 2020-12-09 2021-12-09 Mof nanoparticles Pending AU2021395441A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20212892.2 2020-12-09
EP20212892.2A EP4011365A1 (en) 2020-12-09 2020-12-09 Mof nanoparticles
PCT/EP2021/085108 WO2022122983A1 (en) 2020-12-09 2021-12-09 Mof nanoparticles

Publications (2)

Publication Number Publication Date
AU2021395441A1 true AU2021395441A1 (en) 2023-06-29
AU2021395441A9 AU2021395441A9 (en) 2023-07-27

Family

ID=73790017

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2021395441A Pending AU2021395441A1 (en) 2020-12-09 2021-12-09 Mof nanoparticles

Country Status (6)

Country Link
US (1) US20240050379A1 (https=)
EP (2) EP4011365A1 (https=)
JP (1) JP2024500350A (https=)
AU (1) AU2021395441A1 (https=)
CA (1) CA3201758A1 (https=)
WO (1) WO2022122983A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115505131B (zh) * 2022-09-19 2023-07-11 西南交通大学 氨基功能化的发光金属有机骨架及其制备方法和应用
CN115895152B (zh) * 2022-09-19 2023-12-26 西南交通大学 pH膜传感器、pH膜传感器的制备方法以及pH值的检测方法
CN116036263B (zh) * 2022-12-20 2026-01-13 西南大学 一种基于锆金属有机框架的复合纳米佐剂制剂及其在动物疫苗中的应用
WO2025010407A2 (en) * 2023-07-05 2025-01-09 The University Of Chicago Nanoscale metal-organic frameworks with x-ray triggerable prodrugs for combination radiotherapy, chemotherapy, and immunotherapy
WO2025125382A1 (en) 2023-12-11 2025-06-19 Cambridge Enterprise Limited Mof nanoparticles
WO2025125384A1 (en) 2023-12-11 2025-06-19 Cambridge Enterprise Limited Hydrogel compositions
CN119896750B (zh) * 2025-01-23 2025-11-04 常州大学 一种负载侧柏精油的钾掺杂金属有机骨架抗菌纳米粒及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2921661B1 (fr) * 2007-10-01 2013-05-31 Centre Nat Rech Scient Solide hybride organique inorganique a surface modifiee.
GB2472446A (en) * 2009-08-07 2011-02-09 Ct Fuer Angewandte Nanotechnologie Metal oxide particles coated with polyethylene glycol and their synthesis
CN110731961A (zh) * 2014-10-14 2020-01-31 芝加哥大学 金属有机框架、药物制剂及其在制备药物中的用途
GB201511125D0 (en) 2015-06-24 2015-08-05 Cambridge Entpr Ltd Amorhous metal-organic frameworks
MX2020000387A (es) * 2017-07-13 2020-08-17 Univ Northwestern Método general y directo para preparar nanopartículas de estructura organometálica funcionalizadas con oligonucleotidos.

Also Published As

Publication number Publication date
JP2024500350A (ja) 2024-01-09
AU2021395441A9 (en) 2023-07-27
CA3201758A1 (en) 2022-06-16
EP4011365A1 (en) 2022-06-15
EP4259109A1 (en) 2023-10-18
US20240050379A1 (en) 2024-02-15
WO2022122983A1 (en) 2022-06-16

Similar Documents

Publication Publication Date Title
US20240050379A1 (en) Mof nanoparticles
Chen et al. Formulation of metal–organic framework-based drug carriers by controlled coordination of methoxy PEG phosphate: boosting colloidal stability and redispersibility
Jafari et al. Highly efficient sunitinib release from pH-responsive mHPMC@ Chitosan core-shell nanoparticles
Peracchia et al. Pegylated nanoparticles from a novel methoxypolyethylene glycol cyanoacrylate-hexadecyl cyanoacrylate amphiphilic copolymer
Bilalis et al. pH-Sensitive nanogates based on poly (l-histidine) for controlled drug release from mesoporous silica nanoparticles
Juère et al. On the nanopore confinement of therapeutic drugs into mesoporous silica materials and its implications
Zhao et al. PEGylated mesoporous silica as a redox-responsive drug delivery system for loading thiol-containing drugs
Phan et al. Pancreatic cancer therapy using an injectable nanobiohybrid hydrogel
KR101993297B1 (ko) 변형된 외부 표면을 가진 개선된 유기-무기 하이브리드 고체
Pongjanyakul et al. Enhanced entrapment efficiency and modulated drug release of alginate beads loaded with drug–clay intercalated complexes as microreservoirs
US10272157B2 (en) Porous solid with outer surface grafted with a polymer
Fazio et al. Laser light triggered smart release of silibinin from a PEGylated–PLGA gold nanocomposite
Kong et al. Polyethyleneimine-stabilized hydroxyapatite nanoparticles modified with hyaluronic acid for targeted drug delivery
SG173455A1 (en) Hollow silica particle with a polymer thereon
Liu et al. Enhancing drug delivery efficacy through bilayer coating of zirconium-based metal–organic frameworks: sustained release and improved chemical stability and cellular uptake for cancer therapy
Vergaro et al. Synthesis of biocompatible polymeric nano-capsules based on calcium carbonate: A potential cisplatin delivery system
Zhang et al. A surface-grafted ligand functionalization strategy for coordinate binding of doxorubicin at surface of PEGylated mesoporous silica nanoparticles: Toward pH-responsive drug delivery
Rafati et al. Kinetic study, structural analysis and computational investigation of novel xerogel based on drug-PEG/SiO2 for controlled release of enrofloxacin
Narayan et al. Mesoporous silica nanoparticles capped with chitosan-glucuronic acid conjugate for pH-responsive targeted delivery of 5-fluorouracil
Yang et al. Multifunctional mesoporous silica nanoparticles with different morphological characteristics for in vitro cancer treatment
Yan et al. Templated fabrication of pH-responsive poly (l-glutamic acid) based nanogels via surface-grafting and macromolecular crosslinking
Bedoya et al. Risedronate functionalized layered double hydroxides nanoparticles with bone targeting capabilities
García-Uriostegui et al. Synthesis and characterization of mesoporous silica-g-poly (hydroxyethylmethacrylate) nanohybrid particles as a drug delivery system
Duan et al. Characterization and performance evaluation of pH-sensitive drug delivery of mesoporous silica with honeycomb structure for treatment of cancer
Karimi et al. Study of release behavior of carboplatin from modified immunoglobulin nanoparticles by folic acid: preparation, characterization and analytical approaches

Legal Events

Date Code Title Description
SREP Specification republished